Innovating Works

MAD-CoV 2

Financiado
MEDIZINISCHE UNIVERSITAET WIEN
354.40K€ | Participante
APEIRON BIOLOGICS AG
42.00K€ | Participante
Vironova
1.01M€ | Participante
JLP HEALTH GMBH
1.51M€ | Participante
JLU
600.00K€ | Participante
INSERM TRANSFERT SA
269.88K€ | Participante
STEMCELL TECHNOLOGIES UK LTD
98.00K€ | Participante
IMBA
745.60K€ | Participante